Seneca Financial Advisors LLC Bristol Myers Squibb CO Transaction History

Seneca Financial Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 27, 2025	SELL	$40.25 - $52.99 $188,651 - $248,364	-4,687 Closed	0 $0
Q4 2023 Aug 27, 2025	BUY	$48.48 - $57.85 $227,225 - $271,142	4,687 New	4,687 $240 Million
Q2 2023 Aug 27, 2025	SELL	$63.71 - $70.74 $343,205 - $381,076	-5,387 Closed	0 $0
Q1 2023 Aug 27, 2025	BUY	$65.71 - $74.53 $353,979 - $401,493	5,387 New	5,387 $373 Million

2,674

1.64B

22.4M

25.4M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $93.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Seneca Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Seneca Financial Advisors LLC with notifications on news.